Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 237 clinical trials
  • None views
  • None views
  • None views
  • None views
  • None views
Durvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial Cancer

A study to assess the efficacy and safety of durvalumab in combination with platinum-based chemotherapy (paclitaxel + carboplatin) followed by maintenance durvalumab with or without olaparib for patients with newly diagnosed advanced or recurrent endometrial cancer.

recurrent disease
carcinosarcoma
carboplatin
measurable disease
immunomodulators
  • 0 views
  • 16 Feb, 2024
  • 95 locations
A Study of Sacituzumab Govitecan (IMMU-132) in Endometrial Carcinoma

This is a non-randomized Phase 2 study of sacituzumab govitecan (IMMU-132) in subjects with persistent or recurrent endometrial carcinoma.

recurrent disease
ffpe
x rays
x-rays
prednisone
  • 0 views
  • 16 Feb, 2024
  • 1 location